Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4NET 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 4Colonic Neoplasms 2Neurologic Manifestations 1Neuroendocrine Tumors 1Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Cytidine Triphosphate × Gastrointestinal × Clear all
NCT03990623 2023-04-07

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

M.D. Anderson Cancer Center

Phase NA Unknown
22 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02472249 2021-04-28

Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC

University Health Network, Toronto

Phase 4 Completed
10 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03754192 2020-09-01

PERCAHEC

Assistance Publique - Hôpitaux de Paris

Phase NA Unknown
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01163526 2017-01-30

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Stanford University

Terminated
13 enrolled
EndocrineGastrointestinalNET

Colonic Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Neurologic Manifestations, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡